HAE
Haemonetics Corp
Price:  
71.43 
USD
Volume:  
587,243.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HAE Relative Valuation

11.8%
Upside

As of 2024-02-21, the Relative Valuation of Haemonetics Corp (HAE) is 79.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 71.43 USD, the upside of Haemonetics Corp based on Relative Valuation is 11.8%.

The range of the Relative Valuation is 68.65 - 90.05 USD.

Range Selected
Trailing P/E multiples 29.2x - 35.6x 32.3x
Forward P/E multiples 24.1x - 30.8x 27.4x
Fair Price 68.65 - 90.05 79.83
Upside -3.9% - 26.1% 11.8%
71.43 USD
Stock Price
79.83 USD
Fair Price

HAE Relative Valuation - Historical P/E Data

Date P/E
2024-02-21 28.85
2024-02-20 28.27
2024-02-16 28.64
2024-02-15 28.45
2024-02-14 28.20
2024-02-13 28.38
2024-02-12 29.59
2024-02-09 29.37
2024-02-08 30.91
2024-02-07 30.52
2024-02-06 30.52
2024-02-05 29.83
2024-02-02 30.21
2024-02-01 30.87
2024-01-31 30.26
2024-01-30 31.76
2024-01-29 32.19
2024-01-26 32.18
2024-01-25 32.15
2024-01-24 32.37
2024-01-23 33.16
2024-01-22 33.54
2024-01-19 33.23
2024-01-18 33.05
2024-01-17 32.69
2024-01-16 32.73
2024-01-12 32.85
2024-01-11 32.78
2024-01-10 33.12
2024-01-09 32.94
2024-01-08 33.71
2024-01-05 32.23
2024-01-04 32.38
2024-01-03 32.34
2024-01-02 33.70
2023-12-29 33.84
2023-12-28 34.40
2023-12-27 34.37
2023-12-26 34.32
2023-12-22 34.83
2023-12-21 33.84
2023-12-20 34.11
2023-12-19 34.75
2023-12-18 34.98
2023-12-15 35.30
2023-12-14 35.13
2023-12-13 34.83
2023-12-12 34.22
2023-12-11 33.70
2023-12-08 33.58